Clinical Trials Insight: 700011530
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2007
At a glance
- Drugs ANA 975 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Sponsors Anadys Pharmaceuticals
- 01 Nov 2007 Status changed from initiated to discontinued.
- 24 Jan 2006 New trial record.